Increasing fructose 2,6-bisphosphate overcomes hepatic insulin resistance of type 2 diabetes.
about
14-3-3s regulate fructose-2,6-bisphosphate levels by binding to PKB-phosphorylated cardiac fructose-2,6-bisphosphate kinase/phosphatasePhosphofructo-2-kinase/fructose-2,6-bisphosphatase modulates oscillations of pancreatic islet metabolismSmall molecule inhibition of 6-phosphofructo-2-kinase suppresses t cell activation.Glycolysis, tumor metabolism, cancer growth and dissemination. A new pH-based etiopathogenic perspective and therapeutic approach to an old cancer questionRapamycin treatment benefits glucose metabolism in mouse models of type 2 diabetes.Targeting hepatic glucose metabolism in the treatment of type 2 diabetes.Elucidation of the role of fructose 2,6-bisphosphate in the regulation of glucose fluxes in mice using in vivo (13)C NMR measurements of hepatic carbohydrate metabolism.
P2860
Q24681544-9AF38758-548C-43B8-91AD-080EF14D1660Q27305727-F259AB31-EC45-400F-B7B7-9BA71C6C6C0CQ34271644-0AF9F825-97C8-4992-B9B5-0600ABC55311Q34459681-1A93EFFE-584B-42DC-857D-515100D75D4EQ37538274-7BE5A05D-28E8-4314-8809-B656AD15EEC5Q38925481-4C7C099F-3E6C-49E6-8B40-88ED917D931EQ44135925-C3CCCDF8-3A1D-4B18-A57C-73F6007DB92C
P2860
Increasing fructose 2,6-bisphosphate overcomes hepatic insulin resistance of type 2 diabetes.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh-hant
name
Increasing fructose 2,6-bispho ...... resistance of type 2 diabetes.
@en
Increasing fructose 2,6-bispho ...... resistance of type 2 diabetes.
@nl
type
label
Increasing fructose 2,6-bispho ...... resistance of type 2 diabetes.
@en
Increasing fructose 2,6-bispho ...... resistance of type 2 diabetes.
@nl
prefLabel
Increasing fructose 2,6-bispho ...... resistance of type 2 diabetes.
@en
Increasing fructose 2,6-bispho ...... resistance of type 2 diabetes.
@nl
P2093
P2860
P1476
Increasing fructose 2,6-bispho ...... resistance of type 2 diabetes.
@en
P2093
Alex J Lange
Chaodong Wu
Christopher B Newgard
David A Okar
P2860
P304
P356
10.1152/AJPENDO.2002.282.1.E38
P577
2002-01-01T00:00:00Z